Publication details
Studie AURORA Rosuvastatin a kardiovaskulární příhody u hemodialyzovaných nemocných
| Title in English | AURORA study: Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis |
|---|---|
| Authors | |
| Year of publication | 2009 |
| Type | Article in Periodical |
| Magazine / Source | Intervenční a akutní kardiologie |
| MU Faculty or unit | |
| Citation | |
| Field | Cardiovascular diseases incl. cardiosurgery |
| Keywords | statins; endstage renal disease; hemodialysis; cardiovascular events |
| Description | The AURORA study included 2,776 patients who had been in a regular dialysis programme for at least 3 months. Following randomization, the patients received rosuvastatin at a dose of 10 mg/day or placebo. The combined primary endpoint was cardiovascular death, nonfatal myocardial infarction, or stroke. The study failed to demonstrate an effect of treatment with rosuvastatin on reducing cardiovascular events in dialysis patients. |
| Related projects: |